Aprea Therapeutics (APRE)
News

Recap: Aprea Therapeutics Q1 Earnings
16 May 22
Earnings, News
Aprea Therapeutics Q1 EPS $(0.36) Up From $(0.46) YoY
16 May 22
Earnings, News
Stocks That Hit 52-Week Lows On Friday
6 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Stocks That Hit 52-Week Lows On Friday
22 Apr 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Aprea Shares Update On Its Eprenetapopt Program In Various Blood Cancer Settings
16 Mar 22
Biotech, Earnings, News, Penny Stocks, Health Care, FDA, Movers, Trading Ideas, General
10 Biggest Price Target Changes For Wednesday
16 Mar 22
Penny Stocks, Price Target, Small Cap, Pre-Market Outlook, Analyst Ratings
HC Wainwright & Co. Maintains Neutral on Aprea Therapeutics, Lowers Price Target to $2
16 Mar 22
News, Price Target, Analyst Ratings
RBC Capital Maintains Sector Perform on Aprea Therapeutics, Lowers Price Target to $4
16 Mar 22
News, Price Target, Analyst Ratings
Aprea Therapeutics Q4 EPS $(0.36) Up From $(0.73) YoY
15 Mar 22
Earnings, News
Stocks That Hit 52-Week Lows On Wednesday
23 Feb 22
Stocks That Hit 52-Week Lows On Friday
18 Feb 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
Press releases
Aprea Therapeutics Announces Acquisition of Atrin Pharmaceuticals Inc. and Reports First Quarter 2022 Financial Results
16 May 22
Earnings, M&A, News, Press Releases
Aprea Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Update on Business Operations
15 Mar 22
Earnings, Health Care, Press Releases